A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.
Clinical trial NCT03910660 · COMPLETED
Trial details
- NCT number
- NCT03910660
- Sponsor
- BioXcel Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-12
- Primary completion
- 2023-10-31
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.